SCHEMBL30116166

SCHEMBL30116166

O=C1CCN(c2ccc(Br)cc2F)CC1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.59
KMT2A Q03164 2/20 0.59
HPGD P15428 3/20 0.45
SMN1; SMN2 Q16637 1/20 0.42
MAPT P10636 5/20 0.42
TSHR P16473 2/20 0.42
KDM4E B2RXH2 1/20 0.40
GAA P10253 1/20 0.40
HTT P42858 1/20 0.40
SLC6A5 Q9Y345 1/20 0.40
CCR1 P32246 3/20 0.39
CCR2 P41597 3/20 0.39
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.37
MAPK1 P28482 1/20 0.37
GFER P55789 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
IGF1R P08069 1/20 0.37
ADRA1B P35368 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17543490 1.00 ALDH1A1 (0.59) ALDH1A1KMT2AHPGDSMN1; SMN2MAPT
SCHEMBL14485349 0.82 ALDH1A1 (0.62) ALDH1A1KMT2ASMN1; SMN2MAPTGAA
SCHEMBL25715170 0.82 ALDH1A1 (0.56) ALDH1A1KMT2AHPGDSMN1; SMN2MAPT
SCHEMBL17531636 0.80 ALDH1A1 (0.54) ALDH1A1KMT2AHPGDSMN1; SMN2MAPT
SCHEMBL17543687 0.79 ALDH1A1 (0.59) ALDH1A1KMT2ASMN1; SMN2KDM4EHTT
SCHEMBL5622578 0.79 ALDH1A1 (0.59) ALDH1A1KMT2AHPGDSMN1; SMN2MAPT
SCHEMBL13419298 0.79 ALDH1A1 (0.59) ALDH1A1KMT2AHPGDSMN1; SMN2MAPT
SCHEMBL29931936 0.79 ALDH1A1 (0.59) ALDH1A1KMT2ASMN1; SMN2KDM4EHTT
SCHEMBL21590283 0.79 MAPT (0.48) ALDH1A1KMT2AHPGDSMN1; SMN2MAPT
SCHEMBL17543128 0.79 ALDH1A1 (0.40) ALDH1A1KMT2AHPGDSMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108884044-B Piperidine derivatives 大塚制药株式会社 2023-01-31 CN disclosed